Pulmonary manifestations of systemic autoimmune disease

Best Practice and Research: Clinical Rheumatology

Volumn 18, Issue 3, 2004, Pages 381-410

  Rayner, Charlotte F J ^a   Grubnic, Sisa ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bronchoscopy; Cardiopulmonary exercise testing; Connective tissue disease; Echocardiography; High resolution computed tomography; Interstitial lung disease; Pleural disease; Pulmonary emboli; Pulmonary function tests; Pulmonary hypertension; Respiratory muscle weakness

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; IMMUNOSUPPRESSIVE AGENT; OXYGEN; PENICILLAMINE; RESPIRATORY TRACT AGENT; SILDENAFIL; TRIPROSTINOL; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; BRONCHOSCOPY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION TEST; PATHOLOGICAL ANATOMY; PATHOLOGIST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIOLOGIST; RESPIRATORY TRACT DISEASE; SKILL; SYMPTOMATOLOGY; SYSTEMIC DISEASE; THORACOCENTESIS; THORACOSCOPY; THORAX RADIOGRAPHY;

AUTOIMMUNE DISEASES; BRONCHOSCOPY; DIAGNOSTIC IMAGING; EXERCISE TEST; HUMANS; LUNG DISEASES; PLEURAL DISEASES; RESPIRATORY FUNCTION TESTS; THORACOSCOPY;

EID: 3242682710     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.03.004     Document Type: Article

References (49)

1. Fulmer J.D. Roberts W.C. von Gal E.R. Crystal R.G. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis Journal of Clinical Investigation 63 1979 665-676
2. Bye P.T. Anderson S.D. Woolcock A.J. et al Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen American Review of Respiratory Diseases 126 1982 1005-1012
3. Marciniuk D.D. Gallagher C.G. Clinical exercise testing in interstitial lung disease Clinical Chest Medicine 15 1994 287-303
4. Weisman I.M. Zeballos R.J. Clinical exercise testing Clinical Chest Medicine 22 2001 679-701
5. British Thoracic Society and Association of Respiratory Technicians and Physiologists guidelines for the measurement of respiratory function Respiratory Medicine 88 1994 165-194
6. Harrison B.D.W. Collins J.V. Brown K.G.E. Clark T.J.H. Respiratory failure in neuromuscular disease Thorax 26 1971 579-584
7. British Thoracic Society Bronchoscopy Guideline Committee: a sub-committee of the Standards of Care Committee of the British Thoracic Society Thorax 56 supplement I 2001 i1-i21
8. Ernst A. Silvestri G.A. Johnstone D. American College of Chest Physicians interventional pulmonary procedures: guidelines from the American College of Chest Physicians Chest 123 2003 1693-1717
9. Oliveri D. D'Ippolito R. Chetta A. Induced sputum: diagnostic value in interstitial lung disease Current Opinions in Pulmonary Medicine 6 2000 411-414
10. Ferson P.F. Landreneau R.J. Thoracoscopic lung biopsy or open lung biopsy for interstitial lung disease Chest Surgical Clinics of North America 8 1998 749-762
11. Shah S.S. Tsang V. Goldstraw P. Open lung biopsy: a safe, reliable and accurate method for diagnosis in diffuse lung disease Respiration 59 1992 243-246
12. Kim E.A. Lee K.S. Johkoh T. et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings Radiographics 22 2002 S151-S165
13. Kao A.H. Manzi S. How to manage patients with cardiopulmonary disease? Best Practice and Research Clinical Rheumatology 16 2002 211-227
14. Fagan K.A. Badesch D.B. Pulmonary hypertension associated with connective tissue disease Progress in Cardiovascular Disease 45 2002 225-234
15. Gibbs SR, Higenbottam TW. Recommendations on the management of pulmonary hypertension in clinical practice. Heart. 2001 86 1-11
16. Budev M.M. Arroliga A.C. Jennings C.A. Diagnosis and evaluation of pulmonary hypertension Cleveland Clinic Journal of Medicine 70 supplement 1 2002 S9-S17
17. Nauser T.D. Stites S.W. Pulmonary hypertension: new perspectives Congestive Heart Failure 9 2003 155-162
18. Denton C.P. Black C.M. Pulmonary hypertension in systemic sclerosis Rheumatology Diseases Clinics of North America 29 2003 335-349
19. Tung K.T. Wells A.U. Rubens M.B. et al Accuracy of the typical computed tomographic appearances of fibrosing alveolitis Thorax 48 1993 334-338
20. Fujii M. Adachi S. Shimizu T. et al Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography Journal of Thoracic Imaging 176 1993 755-759
21. Colby T.V. Swensen S.J. Anatomic distribution and histopathologic patterns in diffuse lung disease: correlation with HRCT Journal of Thoracic Imaging 11 1996 1-26
22. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias American Journal of Respiratory and Critical Care Medicine 165 2002 277-304
23. Ellis S.M. Hansell D.M. Idiopathic interstitial pneumonias: imaging-pathology correlation European Radiology 12 2002 610-626
24. Franquet T. High-resolution CT of lung disease related to collagen vascular disease Radiology Clinics of North America 39 2001 11710-11787
25. Wells A.U. Hansell D.M. Rubens M.B. et al The predictive value of appearances of thin-section computed tomography in fibrosing alveolitis American Review of Respiratory Diseases 148 1993 1076-082
26. Remy-Jardin M. Giraud F. Remy J. et al Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation Radiology 189 1993 693-698
27. Lee J.S. Im J.G. Ahn J.M. et al Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT Radiology 184 1992 451-454
28. Ay S.E. Kazerooni E.A. Toews G.B.M. et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival American Journal of Respiratory and Critical Care Medicine 147 1998 1063-72
29. Shaw R.J. Djukanovic R. Tashkin D.P. The role of small airways in lung disease Respiratory Medicine 96 2002 67-80
30. Ikezoe J. Johkoh T. Nohno N. et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis Journal of Thoracic Imaging 11 1996 250-259
31. Stein M.G. Gamsu G. Webb W.R. et al. Computed tomography of diffuse tracheal stenosis in Wegener granulomatosis Journal of Computed Assisted Tomography 10 1986 868-870
32. Mayo J.R. Jackson S.A. High Resolution CT of the chest: radiation dose American Journal of Roentgenology 160 1993 479-481
33. Line B.R. Fulmer J.D. Reynolds H.Y. et al Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation and physiologic and morphologic features and bronchoalveolar lavage American Review of Respiratory Disease 118 1978 355-65
34. aaKoh D.M. Burke S. Davies N. Padley S.P . Transthoracic US of the chest: clinical uses and applications Radiographics 22 2002 1
35. Maskell N.A. Butland R.J.A. on behalf of the British Thoracic Society Pleural Disease Group, a subgroup of the British Thoracic Society Standards of Care Committee BTS guidelines for the investigation of a unilateral pleural effusion in adults Thorax 58 2003 ii8-ii17
36. Light R.W. Pleural Diseases 2001 Lippincott Williams and Wilkins Philadelphia, PA
37. Davies C.W.H. Gleeson F.V. Davies R.J.O. on behalf of the British Thoracic Society, a subgroup of the British Society Standards of Care Committee BTS guidelines for the management of pleural effusions Thorax 58 supplement 11 2003 ii18-ii28
38. Diffuse Parenchymal Lung Disease Group of the British Thoracic Society The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults Thorax 54 supplement I 1999
39. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment American Journal of Respiratory and Critical Care Medicine 161 2000 646-664
40. American Thoracic Society International guidelines for the selection of lung transplant candidates American Journal of Respiratory and Critical Care Medicine 158 1998 335-339
41. Rich S. Kaufman E. Levy P.S. The effects of high doses of calcium channel blockers on survival of primary pulmonary hypertension New England Journal of Medicine 327 1992 76-81
42. Galie N. Humbert M. Vachiery J.L. et al Effect of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary artery hypertension: a randomized, double-blind placebo-controlled trial Journal of the American College of Cardiology 39 2002 1496-1502
43. Olschwski H. Ghofrani H.A. Schmehl T. et al Inhaled iloprost to treat severe pulmonary hypertension; an uncontrolled trial Annals of Internal Medicine 132 2000 435-443
44. Channick R.N. Simmonneau G. Sitbon O. et al Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study Lancet 358 2001 1119-1123
45. Rubin L.J. Badesch D.B. Barst R.J. et al Bosentan in patients with pulmonary arterial hypertension, a randomized, placebo controlled, multicentre study New England Journal of Medicine 346 2002 896-903
46. Peacock A.J. Treatment of pulmonary hypertension. National Pulmonary Hypertension Services of UK and Ireland British Medical Journal 326 2003 835-836
47. Hirsh J. Dalen J. Guyatt G. for the American College of Chest Physicians The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians Chest 119 1 supplement 2001 1S-2S
48. Wood D. Airway stenting Chest Surgery Clinics of North America 3 2003 211-229
49. Wright C.D. Tracheomalacia Chest Surgery Clinics of North America 13 2003 349-357